J. White

NRG-BR002: A Randomized Phase II/III Trial of Metastases-Directed Ablation with First-Line Systemic Therapy for Oligometastatic Breast Cancer

Purpose: Metastasis-directed therapy is increasingly used for oligometastatic breast cancer, despite its uncertain benefit during first-line systemic therapy. We evaluated whether metastasis-directed ablation improves progression-free survival (PFS) compared with first-line systemic therapy alone in patients with oligo...